Progyny (PGNY) Tops Q4 EPS by 32c ; Offers Guidance

Progyny (NASDAQ: PGNY) reported Q4 EPS of $0.42, $0.32 better than the analyst estimate of $0.10. Revenue for the quarter came in at $298.43 million versus the consensus estimate of $275.01 million.

GUIDANCE:

Progyny sees Q1 2025 EPS of $0.44-$0.47, versus the consensus of $0.40. Progyny sees Q1 2025 revenue of $300-318 million, versus the consensus of $280.5 million.

Progyny sees FY2025 EPS of $1.52-$1.62, versus the consensus of $1.66. Progyny sees FY2025 revenue of $1.17-1.22 billion, versus the consensus of $1.16 billion.

For earnings history and earnings-related data on Progyny (PGNY) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
• Raymond James Downgrades V2X, Inc. (VVX) to Market Perform